2.95
price down icon3.28%   -0.10
after-market Dopo l'orario di chiusura: 2.93 -0.02 -0.68%
loading
Precedente Chiudi:
$3.05
Aprire:
$3.1
Volume 24 ore:
222.75K
Relative Volume:
0.12
Capitalizzazione di mercato:
$3.15M
Reddito:
$12.99M
Utile/perdita netta:
$-23.72M
Rapporto P/E:
-0.0303
EPS:
-97.2514
Flusso di cassa netto:
$-23.28M
1 W Prestazione:
-14.74%
1M Prestazione:
-37.50%
6M Prestazione:
-96.58%
1 anno Prestazione:
-98.81%
Intervallo 1D:
Value
$2.9451
$3.1856
Intervallo di 1 settimana:
Value
$2.90
$3.4292
Portata 52W:
Value
$2.81
$485.37

Aptevo Therapeutics Inc Stock (APVO) Company Profile

Name
Nome
Aptevo Therapeutics Inc
Name
Telefono
206-838-0500
Name
Indirizzo
2401 4TH AVE., SEATTLE, WA
Name
Dipendente
37
Name
Cinguettio
@aptevo
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
APVO's Discussions on Twitter

Confronta APVO con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
APVO
Aptevo Therapeutics Inc
2.95 3.15M 12.99M -23.72M -23.28M -97.25
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.16 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
534.91 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.06 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
542.47 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.16 28.51B 3.81B -644.79M -669.77M -6.24

Aptevo Therapeutics Inc Stock (APVO) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2018-11-05 Iniziato Ladenburg Thalmann Buy
2017-10-05 Ripresa Piper Jaffray Overweight

Aptevo Therapeutics Inc Borsa (APVO) Ultime notizie

pulisher
Jun 18, 2025

Top Small Cap Stocks Worth WatchingJune 18th - MarketBeat

Jun 18, 2025
pulisher
Jun 18, 2025

Crude Oil Moves Higher; US Weekly Jobless Claims Decline - Benzinga

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo Therapeutics raises $8 million in registered direct offering - Investing.com Australia

Jun 18, 2025
pulisher
Jun 18, 2025

Dow Surges 150 Points; Korn Ferry Earnings Top Views - Benzinga

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo Therapeutics (APVO) Secures $8M Through Direct Offering - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo Therapeutics announces $8M at-the-market equity offering with warrants; shares more than double - MSN

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo Therapeutics raises $8 million in registered direct offering By Investing.com - Investing.com India

Jun 18, 2025
pulisher
Jun 18, 2025

Why Is Micro-Cap Aptevo Stock Trading Higher On Wednesday?Aptevo Therapeutics (NASDAQ:APVO) - Benzinga

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo Therapeutics Announces $8 Million Offering Priced At-the-Market Under Nasdaq Rules | APVO Stock News - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

An early stage 85% remissions rate in AML drives Aptevo’s stock surge - BioWorld MedTech

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo Therapeutics Announces $8 Million Offering Priced At-the-Market Under Nasdaq Rules - ACCESS Newswire

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo Secures $8M Funding: Biotech Company Accelerates Cancer Drug Development Pipeline - Stock Titan

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo Therapeutics stock soars after impressive AML treatment results - Investing.com

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo Therapeutics stock soars after impressive AML treatment results By Investing.com - Investing.com Canada

Jun 18, 2025
pulisher
Jun 18, 2025

Why did Aptevo Therapeutics Shares Skyrocket in Premarket Trading Today? - Tokenist

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo Therapeutics Skyrockets on Game-Changing AML Drug News - RagingBull

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo reports 85% remission rate in frontline AML trial By Investing.com - Investing.com Nigeria

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo Therapeutics (APVO) Shows Promising Results in RAINIER Tr - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo Says Its Mipletamig Therapy Achieves 85% Remission Rate in Leukemia Patients; Shares Soar Pre-Bell - MarketScreener

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo Therapeutics (APVO) Shows Promising Results in AML Trial - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo Therapeutics announces new clinical data from RAINIER trial - TipRanks

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo announces clinical data from ongoing Phase 1b/2 RAINIER trial - TipRanks

Jun 18, 2025
pulisher
Jun 18, 2025

Breakthrough AML Drug Achieves 85% Remission Rate: New Hope for Previously Untreatable Patients - Stock Titan

Jun 18, 2025
pulisher
Jun 17, 2025

Aptevo Therapeutics Signs Equity Purchase Agreement - TipRanks

Jun 17, 2025
pulisher
Jun 16, 2025

APVO Secures Roth Capital Partners as Exclusive Placement Agent - GuruFocus

Jun 16, 2025
pulisher
Jun 15, 2025

Short Interest in Aptevo Therapeutics Inc. (NASDAQ:APVO) Decreases By 55.0% - Defense World

Jun 15, 2025
pulisher
Jun 14, 2025

Aptevo Stock Rises On $2.1M Registered Direct Offering, Warrant Sale: Retail Sentiment Touches Year-High - MSN

Jun 14, 2025
pulisher
Jun 13, 2025

Aptevo Participating in the BIO International Convention | APVO Stock News - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

Aptevo Sends Business Development Team to BIO 2025: Major Partnership Opportunities Ahead - Stock Titan

Jun 13, 2025
pulisher
May 29, 2025

Aptevo Therapeutics Inc. (NASDAQ:APVO) Sees Large Decrease in Short Interest - Defense World

May 29, 2025
pulisher
May 25, 2025

Aptevo Therapeutics (APVO) Trading Suspended as News Awaits | AP - GuruFocus

May 25, 2025
pulisher
May 23, 2025

Aptevo Therapeutics (APVO) Trading Suspended as News Awaits | APVO Stock News - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Aptevo Therapeutics Approves 1-for-20 Reverse Stock Split - TipRanks

May 23, 2025
pulisher
May 22, 2025

Aptevo Therapeutics Announces Reverse Stock Split - TipRanks

May 22, 2025
pulisher
May 22, 2025

Aptevo Therapeutics to Implement 1-for-20 Reverse Stock Split - marketscreener.com

May 22, 2025
pulisher
May 22, 2025

Aptevo Therapeutics Announces 1-for-20 Reverse Stock Split as pa - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Aptevo Therapeutics (APVO) Announces 1-for-20 Reverse Stock Split | APVO Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Aptevo Therapeutics enacts reverse stock split to maintain Nasdaq compliance - Investing.com

May 22, 2025
pulisher
May 22, 2025

Aptevo Therapeutics Announces 1-for-20 Reverse Stock Split as part of Nasdaq Compliance Plan - ACCESS Newswire

May 22, 2025
pulisher
May 22, 2025

Aptevo's Dramatic 1:20 Reverse Split Cuts Shares from 13.5M to 0.7M in Nasdaq Compliance Push - Stock Titan

May 22, 2025
pulisher
May 18, 2025

StockNews.com Begins Coverage on Aptevo Therapeutics (NASDAQ:APVO) - Defense World

May 18, 2025
pulisher
May 16, 2025

Aptevo Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 16, 2025
pulisher
May 15, 2025

Aptevo reports high remission in AML patients with new drug By Investing.com - Investing.com South Africa

May 15, 2025
pulisher
May 15, 2025

APVO: Promising Trial Results Propel AML Treatment Innovations | - GuruFocus

May 15, 2025
pulisher
May 15, 2025

APVO: Promising Trial Results Propel AML Treatment Innovations | APVO Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Aptevo reports high remission in AML patients with new drug - Investing.com Australia

May 15, 2025
pulisher
May 15, 2025

Aptevo Therapeutics Reports 1Q25 Financial Results And Provides an Update on Mipletamig | APVO Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Aptevo Therapeutics Reports 1Q25 Financial Results And Provides an Update on Mipletamig - ACCESS Newswire

May 15, 2025
pulisher
May 14, 2025

Breakthrough: New AML Drug Shows 90% Remission Rate With Zero Cytokine Release Syndrome - Stock Titan

May 14, 2025
pulisher
May 12, 2025

Aptevo Therapeutics (APVO) Expected to Announce Earnings on Wednesday - Defense World

May 12, 2025
pulisher
May 10, 2025

Aptevo Therapeutics (NASDAQ:APVO) Now Covered by Analysts at StockNews.com - Defense World

May 10, 2025

Aptevo Therapeutics Inc Azioni (APVO) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
Capitalizzazione:     |  Volume (24 ore):